Overview
The Young-Onset Colorectal Cancer Center at Penn Medicine’s Abramson Cancer Center is dedicated to the clinical care of individuals with Lynch syndrome, as well as to advancing education, outreach, and research related to this hereditary condition.
Lynch syndrome is the most common hereditary cause of colorectal cancer and also confers an elevated lifetime risk for cancers of the endometrium, ovary, stomach, small intestine, urinary tract, and other sites. Our multidisciplinary team partners with patients and families to deliver personalized surveillance and risk-reducing care.
Our Pillars
- Clinical Care — coordinated, multidisciplinary management of Lynch syndrome.
- Research — pilot funding and clinical studies to translate discovery into care.
- Education — programming for patients, families, trainees, and clinicians.
- Outreach — expanding access to genetic testing and counseling.
A Partnership Across Penn Medicine
The Center convenes expertise from gastroenterology, medical oncology, surgical oncology, gynecologic oncology, urology, and clinical genetics, working alongside genetic counselors, nurse navigators, and research staff.